Cosmos Health Inc. has entered into a significant financing agreement with an institutional investor. The company announced the completion of an Initial Closing under a Securities Purchase Agreement dated August 5, 2025. As part of this agreement, Cosmos Health issued a 9% original issue discount senior secured convertible promissory note with a principal amount of $8 million. The note matures on August 7, 2027, with interest payable in shares of Cosmos Health common stock. This transaction, conducted as a private offering, capitalizes on an exemption from registration under the Securities Act of 1933. The note ranks senior to all current and future indebtedness of the company, barring specific permitted debts.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。